CRISPR Therapeutics
Blood & Organ Banks · Switzerland · 201-500 Employees
View Company Info for Free
Overview
Headquarters
Baarerstrasse 14, Zug, Zug, 6300, Switze...Phone Number
+41 415613277Website
www.crisprtx.comRevenue
$11 MillionStock Symbol
CRSPIndustry
About CRISPR Therapeutics
CRISPR Therapeutics is a biotechnology company headquartered in Zug, Switzerland, with additional operations in Boston, San Francisco, and London. Founded in 2013, the company pioneers CRISPR/Cas9 gene-editing technology to develop transformative medicines for serious diseases, including sickle cell disease, beta thalassemia, various cancers, diabetes, and cardiovascular conditions. It co-developed Casgevy, the first approved CRISPR-based therapy, in collaboration with Vertex Pharmaceuticals, and maintains strategic partnerships with leading biopharma organizations to advance its diverse therapeutic pipeline.Explore more
SIC Code 28,283NAICS Code 32,325Ticker NASDAQ: CRSPShow moreCRISPR Therapeutics Org Chart
CRISPR Therapeutics Tech Stack
A closer look at the technologies used by CRISPR Therapeutics
See more technologies
Top Blood & Organ Banks Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding CRISPR Therapeutics
Sign Up For FreeTo access detailed company insights
CRISPR Therapeutics is a biotechnology company headquartered in Zug, Switzerland, with additional operations in Boston, San Francisco, and London. Founded in 2013, the company pioneers CRISPR/Cas9 gene-editing technology to develop transformative medicines for serious diseases, including sickle cell disease, beta thalassemia, various cancers, diabe... Read More
